Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 10 studies | 35% ± 19% | |
oligodendrocyte | 7 studies | 26% ± 13% | |
oligodendrocyte precursor cell | 7 studies | 27% ± 11% | |
retina horizontal cell | 6 studies | 23% ± 7% | |
adipocyte | 6 studies | 24% ± 5% | |
GABAergic neuron | 6 studies | 36% ± 18% | |
glutamatergic neuron | 4 studies | 45% ± 13% | |
interneuron | 4 studies | 38% ± 20% | |
cardiac muscle cell | 3 studies | 17% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 43% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1381.40 | 2631 / 2642 | 99% | 3.64 | 698 / 705 |
adrenal gland | 98% | 733.26 | 254 / 258 | 85% | 1.93 | 195 / 230 |
prostate | 96% | 798.30 | 236 / 245 | 80% | 1.36 | 402 / 502 |
breast | 99% | 644.49 | 453 / 459 | 75% | 1.35 | 844 / 1118 |
thymus | 96% | 533.98 | 630 / 653 | 66% | 1.11 | 399 / 605 |
kidney | 98% | 649.36 | 87 / 89 | 62% | 1.07 | 560 / 901 |
skin | 72% | 299.58 | 1295 / 1809 | 78% | 1.97 | 368 / 472 |
uterus | 98% | 879.10 | 167 / 170 | 39% | 0.70 | 180 / 459 |
ovary | 99% | 674.11 | 178 / 180 | 27% | 0.44 | 115 / 430 |
lung | 91% | 482.40 | 524 / 578 | 33% | 0.54 | 383 / 1155 |
esophagus | 87% | 1667.47 | 1263 / 1445 | 34% | 0.55 | 63 / 183 |
bladder | 90% | 1548.14 | 19 / 21 | 25% | 0.41 | 125 / 504 |
liver | 89% | 411.70 | 201 / 226 | 23% | 0.31 | 93 / 406 |
intestine | 92% | 1800.53 | 893 / 966 | 16% | 0.23 | 86 / 527 |
stomach | 79% | 766.42 | 283 / 359 | 21% | 0.43 | 61 / 286 |
blood vessel | 100% | 1360.76 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 4787.79 | 803 / 803 | 0% | 0 | 0 / 0 |
adipose | 97% | 678.12 | 1167 / 1204 | 0% | 0 | 0 / 0 |
heart | 93% | 1375.98 | 798 / 861 | 0% | 0 | 0 / 0 |
spleen | 92% | 438.97 | 222 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 85% | 2.57 | 68 / 80 |
pancreas | 48% | 177.87 | 156 / 328 | 34% | 0.54 | 60 / 178 |
lymph node | 0% | 0 | 0 / 0 | 69% | 1.37 | 20 / 29 |
tonsil | 0% | 0 | 0 / 0 | 22% | 0.32 | 10 / 45 |
peripheral blood | 21% | 138.48 | 194 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0046835 | Biological process | carbohydrate phosphorylation |
GO_0006470 | Biological process | protein dephosphorylation |
GO_0045786 | Biological process | negative regulation of cell cycle |
GO_0001558 | Biological process | regulation of cell growth |
GO_0005978 | Biological process | glycogen biosynthetic process |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0046959 | Biological process | habituation |
GO_0000045 | Biological process | autophagosome assembly |
GO_0005977 | Biological process | glycogen metabolic process |
GO_0015813 | Biological process | L-glutamate transmembrane transport |
GO_0032007 | Biological process | negative regulation of TOR signaling |
GO_0035335 | Biological process | peptidyl-tyrosine dephosphorylation |
GO_0031396 | Biological process | regulation of protein ubiquitination |
GO_0007005 | Biological process | mitochondrion organization |
GO_0016239 | Biological process | positive regulation of macroautophagy |
GO_0033137 | Biological process | negative regulation of peptidyl-serine phosphorylation |
GO_0016055 | Biological process | Wnt signaling pathway |
GO_1903076 | Biological process | regulation of protein localization to plasma membrane |
GO_0061136 | Biological process | regulation of proteasomal protein catabolic process |
GO_0006816 | Biological process | calcium ion transport |
GO_0042306 | Biological process | regulation of protein import into nucleus |
GO_0014009 | Biological process | glial cell proliferation |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0005886 | Cellular component | plasma membrane |
GO_0098556 | Cellular component | cytoplasmic side of rough endoplasmic reticulum membrane |
GO_0043204 | Cellular component | perikaryon |
GO_0005634 | Cellular component | nucleus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0030425 | Cellular component | dendrite |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_2001070 | Molecular function | starch binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0017018 | Molecular function | myosin phosphatase activity |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0019203 | Molecular function | carbohydrate phosphatase activity |
GO_0004722 | Molecular function | protein serine/threonine phosphatase activity |
GO_2001069 | Molecular function | glycogen binding |
GO_0004373 | Molecular function | glycogen (starch) synthase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004725 | Molecular function | protein tyrosine phosphatase activity |
Gene name | EPM2A |
Protein name | Laforin, isoform 9 EPM2A glucan phosphatase, laforin Laforin (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (Glucan phosphatase) (Glycogen phosphatase) (Lafora PTPase) (LAFPTPase) |
Synonyms | |
Description | FUNCTION: Plays an important role in preventing glycogen hyperphosphorylation and the formation of insoluble aggregates, via its activity as glycogen phosphatase, and by promoting the ubiquitination of proteins involved in glycogen metabolism via its interaction with the E3 ubiquitin ligase NHLRC1/malin. Shows strong phosphatase activity towards complex carbohydrates in vitro, avoiding glycogen hyperphosphorylation which is associated with reduced branching and formation of insoluble aggregates . Dephosphorylates phosphotyrosine and synthetic substrates, such as para-nitrophenylphosphate (pNPP), and has low activity with phosphoserine and phosphothreonine substrates (in vitro) . Has been shown to dephosphorylate MAPT (By similarity). Forms a complex with NHLRC1/malin and HSP70, which suppresses the cellular toxicity of misfolded proteins by promoting their degradation through the ubiquitin-proteasome system (UPS). Acts as a scaffold protein to facilitate PPP1R3C/PTG ubiquitination by NHLRC1/malin . Also promotes proteasome-independent protein degradation through the macroautophagy pathway . .; FUNCTION: [Isoform 2]: Does not bind to glycogen . Lacks phosphatase activity and might function as a dominant-negative regulator for the phosphatase activity of isoform 1 and isoform 7 . .; FUNCTION: [Isoform 7]: Has phosphatase activity (in vitro). . |
Accessions | ENST00000450221.6 ENST00000367519.9 [O95278-1] B3EWF7 ENST00000640351.1 ENST00000638778.1 [O95278-8] ENST00000639049.1 ENST00000638554.1 ENST00000638262.1 [O95278-5] ENST00000639849.1 ENST00000611340.5 [O95278-8] A0A1W2PPT8 ENST00000638717.1 A0A1W2PP62 ENST00000639423.1 [O95278-8] ENST00000638783.1 [O95278-8] ENST00000640225.1 A0A1W2PPJ6 A0A1W2PRC9 ENST00000639465.1 [O95278-8] A0A1W2PQ84 O95278 ENST00000640980.1 H0Y7S8 A0A1W2PRS5 ENST00000435470.2 [O95278-2] |